Transcutaneous electrical nerve stimulation (TENS) delivers low-level electrical current through surface electrode pads to modulate pain perception. The mechanism is well-established: high-frequency TENS activates the gate control pathway in the spinal cord, while low-frequency burst TENS triggers endogenous opioid release. Both provide real — if modest — symptomatic pain relief for musculoskeletal and neuropathic pain.
Consumer OTC TENS units range from $35 budget wired devices to $149 app-guided wireless pods. The stimulation quality across this price range is broadly comparable — the premium at the wireless end buys convenience and app guidance, not better pain relief. Most users find a $35–$65 wired device covers their pain management needs without the wireless premium.
GreatHealthGear evaluates TENS devices by aggregating independent user reviews, published specifications, clinical TENS research, and brand credibility data. No devices are tested in-house. Scores reflect the weight of aggregated external evidence. All OTC device picks are FDA 510(k) cleared.